Article

jdsupra.comjdsupra.com on 2024-02-02 17:48

Biosimilar Regulatory Updates - February 2024

On January 28, 2024, Celltrion USA announced that it has completed submission of its application to the FDA for CT-P47, its proposed tocilizumab ...

Related news